Imidazole → Tert-butyl(2-methoxy-5-nitrophenoxy)dimethylsilane

HRID 47599

반응식

HRID 47599 반응식
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([N+:9]([O-:11])=[O:10])=[CH:5][C:4]=1[OH:12].N1C=CN=C1.[Si:18](Cl)([C:21]([CH3:24])([CH3:23])[CH3:22])([CH3:20])[CH3:19]>CN(C=O)C>[Si:18]([O:12][C:4]1[CH:5]=[C:6]([N+:9]([O-:11])=[O:10])[CH:7]=[CH:8][C:3]=1[O:2][CH3:1])([C:21]([CH3:24])([CH3:23])[CH3:22])([CH3:20])[CH3:19]

참가 물질

5

실험 절차

To a mixture of 2-methoxy-5-nitrophenol (1.53 g, 9.0 mmol) and imidazole (1.08 g, 15.9 mmol) in anhydrous DMF (40 mL) was added, with stirring, tert-butyldimethylsilyl chloride (2.05 g, 13.6 mmol) and the mixture was allowed to stir at room temperature for 16 h. The solvent was removed in vacuo and the residue was dissolved in 40 mL of 50% ethyl acetate in hexanes and filtered through 10 g of silica gel. The silica gel was washed with an additional 200 mL of 50% ethyl acetate in hexanes and the filtrates were combined and concentrated in vacuo to give 2.01 g of product as a tan crystalline solid. 1H NMR (CDCl3) δ 7.89 (dd, 1H, J=9.0 Hz, 2.8 Hz), 7.69 (d, 1H, J=2.8 Hz), 6.88 (d, 1H, J=9.0), 3.90 (s, 3H), 1.00 (s, 9H), 0.18 (s, 6H).

후처리

  1. additionwas added
  2. stirringto stir at room temperature for 16 h
  3. customThe solvent was removed in vacuo
  4. dissolutionthe residue was dissolved in 40 mL of 50% ethyl acetate in hexanes
  5. filtrationfiltered through 10 g of silica gel
  6. washThe silica gel was washed with an additional 200 mL of 50% ethyl acetate in hexanes
  7. concentrationconcentrated in vacuo

출처 및 근거

ORD 기록
ord-8a008bd90e9c463d915f3845e30dae6e
출처 데이터셋
uspto-grants-2004_03
특허 번호
US06699890B2

연결된 노트

불러오는 중…